Hellenic Red Cross Hospital Report issue

Academic/Hospital

Organization Overview

First Clinical Trial
2012
NCT02171299
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Hellenic Red Cross Hospital | JDN-Hellas / Department of Vascular Surgery, Hellenic Red Cross Hospital | Korgiallenio benakeio hellenic red cross hospital

Active Ingredients

Drugs in Other Trials (4)

alfacalcidol (1 trial)

calcium (1 trial)

epinephrine (levophed) (1 trial)

ropivacaine (naropin) (1 trial)

Indications

Overview

  • Highest Phase: Phase 0
  • # of Trials: 3
  • # of Trial APIs: 4